Skip to main content
Signal8

Tamboli Ajim

SEC insider (Form 3/4/5 filer). CIK 0001855684. Chief Financial Officer at First Tracks Biotherapeutics, Inc. (TRAX). 6 reported Form 4/5 transactions since Sep 2024; latest on May 12, 2026. Located in SAN DIEGO, CA.

Companies Tamboli Ajim has filed insider reports for

  • First Tracks Biotherapeutics, Inc. (TRAX): Officer, Chief Financial Officer
Tamboli Ajim profile photo

Tamboli Ajim

CIK: 0001855684

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

First Tracks Biotherapeutics, Inc. logo
TRAX

First Tracks Biotherapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    May 12, 2026
    Award

    Restricted Stock Unit

    Direct
    5K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    May 12, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    13.6K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Apr 23, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    41.2K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Apr 22, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    41.2K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Apr 21, 2026
    Award

    Restricted Stock Unit

    Direct
    45.7K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Apr 21, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    41.2K shares-

1-6 of 6